Pascal Pigny

13PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersMicroelectromechanical systems (MEMS)AutoimmunityHaematological tumoursGenetic immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 14, 2026
Pre-treatment AMH levels suggesting PCOM do not prevent chemotherapy-induced ovarian damage despite higher long-term ovarian reserve: a longitudinal study in 467 women treated with alkylating agents.

|May 18, 2026
MLH1 Constitutional Epimutation Screening Requires Highly Sensitive Assays to Identify Lynch Syndrome Patients With Very Low Mosaic Methylation Level.

|Apr 18, 2026
Inverse relationship between Epstein-Barr virus serostatus and anti-glutamic acid decarboxylase autoantibody levels.

|Apr 12, 2025
AMH decline during chemotherapy reflects breast cancer cell DNA damage response (DDR) proficiency: the ONCO AMH1 pilot study.

Christine Decanter, Audrey Dassonneville, Emmanuelle D'Orazio

|Nov 18, 2023
Update of the UMD-VHL database: classification of 164 challenging variants based on genotype-phenotype correlation among 605 entries.

Gregory Mougel, Amira Mohamed, Nelly Burnichon

|Mar 15, 2023
Changes in circulating forms of anti-Muüllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy.

M Peigné, V Simon, P Pigny

Pageof 3

Frequent Collaborators

1 joint publications

M Peigné

1 joint publications

N E H Mimouni

1 joint publications

D Dewailly

1 joint publications

P Giacobini